UCP Biomaterials and Biomedical Technology’s Post

📯 Remember to register before 2nd of May! Link below. UPM Biomedicals and CSEM are organizing a TEDD Visit with TEDD Competence Centre at Switzerland Innovation Park Basel Area on May 7th! Read more about the program and interesting topics 👉 https://lnkd.in/ge3syZe

We celebrate yesterday a fruitful meeting to discuss the updates and progress on the FLASHon Chip Consortium project from líneas estratégicas funded by Ministerio de Ciencia, Innovación y Universidades AGENCIA ESTATAL DE INVESTIGACIÓN. We would like to thanks our partners Universidad Complutense de Madrid CMAM, and IdISSC and specially to Institute for Bioengineering of Catalonia (IBEC) for hosting us and coordinate this meeting. We shared our latest results and insights on how the Integration of miniaturized and tailored made devices with flash radiotherapy can enhance precision in targeting tumors, reduce collateral damage to healthy tissues, and enable real-time monitoring of treatment efficacy. This synergy promises more effective and safer cancer treatments, pushing the boundaries of current radiotherapy techniques. Let’s go! 🚀🚀🚀 #consortium #lineasEstrategicas #FLASHradiotherapy #microfluidics #cellularmetabolism #cancer

This week, Hologenomix Life Sciences became the first company to utilize our brand-new 𝐒𝐡𝐚𝐫𝐞𝐝 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐋𝐚𝐛 at Biotech Campus Delft! 🌱 This exciting milestone marks a new chapter in our journey to accelerate innovation in biotech. Hologenomix is a pioneering force in the field of multi-omics to develop early disease diagnosis tools. Their innovative approach aims to revolutionize healthcare by enabling more precise and early detection of diseases, ultimately improving patient outcomes. By choosing our facilities, Hologenomix is setting the tone for the transformative work that will take place here. Our Shared Service Lab, a fully equipped ML-2 lab of 63 m², provides a unique, low-barrier environment to boost your innovation. This dynamic environment allows you to conduct experiments, initiate and develop your cutting-edge technologies, and accelerate your research without the need for significant upfront investments. For a fixed monthly fee, you can rent a lab bench for periods ranging from 1 to 12 months. Our facilities include specialized equipment and expert support tailored for various applications, including particularly DNA assembly and strain engineering. Also, if you are looking for a lab to perform strain screening, media selection experiments, process development, and downstream processing such as product formulation and application, please get in contact to discuss possibilities. 🚀 If you're a scientist, startup, or company eager to contribute to the next big breakthrough in biotech, our doors are open! Join us and be part of a thriving community dedicated to creating a sustainable future through biotechnology. For more information, reach out to Jasper Driessen today. Our Shared Service Lab is co-funded by the European Union. #PlanetBio #BiotechInnovation #Biotechnology #Sharedlab #MultiOmics #EarlyDiagnosis #BiotechCampusDelft #SustainableFuture

Exciting News! Our CEO, Maria Jose Borreguero Figols, has been selected to join the prestigious #EUeic #PanelofExperts at the upcoming Tech Demo Day focusing on #MedicalTechnologies and #MedicalDevices on May 15th. The European Innovation Council and SMEs Executive Agency (EISMEA) program #EICT2M is dedicated to empowering #EIC Pathfinder & EICTransition beneficiaries, aiding them in translating #Scientific breakthroughs into thriving #spin-off companies. Parc Científic de Barcelona Parc de Recerca UAB Biocat, BioRegion of Catalonia ACCIÓ Universitat Politècnica de Catalunya (UPC) Universitat de Barcelona

🔬 Unlock the Potential of Your Bioscience Innovations with #ICUReExplore 🚀 Are you ready to take your bioscience idea, product or service to the next level? The BBSRC-National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) ICURe Explore programme is your gateway to transforming scientific research into commercial success. ICURe Explore takes the scientific method (hypothesise, test, evaluate) and applies it to commercialisation. You will learn how to use this approach to test what your potential customers think about your bioscience idea, product or service. 💡 In addition, you will receive training and interview practice, and will be carrying out over 100 interviews across the marketplace and acquiring transferrable business and social skills. 📚 🌍 Start your application today and transform your bioscience research into a viable commercial opportunity. 🔗 https://lnkd.in/e6vHa2b2 Powered by Innovate UK Delivered by The Helix Way   #ICURe #BBSRC #NC3Rs #bioscience #innovation 

SBMC, High Tech NL, and BOM join forces for biomedical innovation > Smart BioMaterials Consortium (SBMC), High Tech NL, and the BOM (Brabantse Ontwikkelings Maatschappij) are collaborating to accelerate innovations in regenerative medicine. Juliette van den Dolder has been appointed as an Innovation Designer with the goal of accelerating the development of production technology for regenerative therapies and connecting the SBMC ecosystem with the NXTGEN Hightech program 'biomedical production technology', supported by High Tech NL. Read more > https://lnkd.in/eP4ewwbv #lifescience, #biomedical, #innovation, #healthcare, #biotechnology, #engineering, #biosensing, #organonchip, #labonchip, #regenerativetherapy Jan Rietsema, Ingrid Relou, PhD, Thomas van Erp, Willem Endhoven

The current Polish legal system does not sufficiently support #innovative activities, based on advanced knowledge and creating new technologies. Primarily reproductive projects are financed, which do not provide opportunities to build advantages for the Polish economy on an #international scale. Changes are necessary, because otherwise it may lead to: ➡ reversal of processes of strengthening #cooperation between the academic and business communities 🤝 ➡ loss of global competitiveness and #Poland's dependence on foreign technologies 🎈 ➡ leakage of #talent from the life sciences sector to the foreign market 🛫 ➡ a slowdown in economic #growth 📉

My talk entitled " Development of Converging BioMedical Platform Technologies: Towards Industry Academia Collaborations and Deep Science Startups " was well received by industry delegates Department of Science and Technology secretary Prof. Abhay Karandikar emphasized the importance on working on Technology Development, IP, Industry-Academia partnerships for nation building which our group has been doing for the last 10+ years. Working on development of two different biomedical technologies especially during tenure-track was pretty scary!!! We have come long way faced many challenges and obstacles converted them into opportunities. I take this opportunity to thank my students, collaborators and funding agency in believing in my vision. last but least the one slide captured attention of everybody is that our group contribution of number of Granted US patents in all IISERs and NISER. Next time anybody this cannot be India please do not listen to them. #technology #biomedical #chemicalbiology #patents #IP #technology #ABRGT #MAPLabTech #BrittoLab #ANRF #DST #IISERPune #Brittolab #industryacademiapartnership #techtransfer #deepsciencestartups

How are my friends in Biotech feeling about the new announcements, launched today, to drive innovation in science? "Dr Joe Marshall, Chief Executive of the The National Centre for Universities and Business (NCUB), said: “The Government has today announced several initiatives to mark the first anniversary of the Department for Science, Innovation and Technology. The creation of a dedicated department for science and innovation shows that the Government has rightly acknowledged that R&D is a key driver of growth. This will be vital if we are to meet the goal of becoming a 'Science and Technology Superpower'. However, to overcome long-term stagnation and foster growth, the UK must take a step forward, and further prioritise research and innovation. It is imperative that the Government builds a focused, cross-departmental approach to deliver a comprehensive and holistic research and innovation policy. Only then will it meet its own goal of becoming a true 'Science and Technology Superpower'.” #science #biotech #technology

🌱 Scope Biosciences; a WUR campus resident Scope Biosciences is a startup that has rapidly evolved from a spinoff of the laboratory Microbiology at Wageningen University & Research to a key player in molecular diagnostics for the Agri-Food sector in just four years. Founded by Niek Savelkoul and fellow co-founders, Scope Biosciences specializes in developing on-site highly accurate molecular diagnostics using CRISPR-Cas technology. This innovative approach allows for the rapid identification of specific viruses and bacteria, making their test a game-changer, compared to the well-known, but laboratory-based PCR, in the Agri-Food sector. Its simplicity and on-site applicability make it invaluable for plant breeders, allowing them to quickly screen for various plant pathogens. 🌍 Impact Beyond Agri-Food: While their primary focus is the Agri-Food sector, the technology also holds promise in the medical domain. The collaboration with GenDx showcases the versatility of the CRISPR diagnostics system in medical diagnostics, aiming for rapid analysis in critical situations. The team has grown to seven dedicated WUR alumni, while also working closely with CRISPR-Cas researchers John van der Oost and Raymond Staals. They were initially offered the opportunity to use lab space in the AFSG Laboratory of Microbiology to start the research and later moved to Plus Ultra I. Wageningen Campus provides valuable lab space and proximity to collaborators. As Scope Biosciences seeks clients globally, they are gearing up for increased production, with plans to expand our labs in Plus Ultra I. The vision is to continue growing, fuelled by awards and investor support. #ScopeBiosciences #AgriFood #CRISPRDiagnostics #Innovation #WageningenCampus #Biotech #StartupSuccess